Home » Topics » Disease categories and therapies » Infection

Infection
RSS

AmBisome cleared by FDA

Aug. 13, 1997

Settlement reached in NeXstar and The Liposome Company patent litigation

Aug. 12, 1997

Oral carbapenem antibacterial agents from Lederle (Japan)

Aug. 11, 1997

AmBisome approved in Korea

Aug. 8, 1997

Shionogi's beta-lactam antibiotic launched in Japan

Aug. 7, 1997

CytoGam approved for marketing in Canada

Aug. 7, 1997

AmBisome approved in Russia

Aug. 7, 1997

New cephems active against MRSA

Aug. 6, 1997

BE-44651B disclosed in patent literature by Banyu

Aug. 6, 1997

EGS oligozymes make drug-resistant bacteria sensitive

Aug. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...